RepliCel Life Sciences completes private placement

Regenerative medicine company RepliCel Life Sciences Inc. (TSX-V:RP; OTCQB:REPCF) raised C$3.2 million ($2.4 million) in concurrent private placements on Feb. 24. In a private placement brokered by E...